Search Results 1111-1120 of 18062 for multiple%20sclerosis

  1. Lenalidomide and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This phase II trial studies how well lenalidomide and dexamethasone work in treating patients with relapsed or refractory multiple myeloma ...

  2. Brain tumor - Doctors and departments - Mayo Clinic

    Rafid Mustafa, M.D.. Neurologist. Rochester, MN. Areas of focus: Stroke, Meningitis, Brain tumor, Multiple sclerosis, Transverse myelitis, Guillain Barre ...

  3. Publications - Elizabeth A. Boots, Ph.D., L.P. - Mayo Clinic

    2024 Dec; 20 Suppl 3:e085612. View PubMed; Boots EA ... 2024 Dec; 20 Suppl 3:e085992 ... Liver kinase B1 rs9282860 polymorphism and risk for multiple sclerosis in ...

  4. The future will be personalized: Accelerating microbiome research - Mayo Clinic News Network

    In another project, Mayo Clinic has licensed a bacteria to a biotechnology company for further study about its role in suppressing multiple sclerosis and ...

  5. Projects - Regenerative Neurobiology Lab - Mayo Clinic Research

    Therapy for amyotrophic lateral sclerosis (ALS). Therapy for ALS. Amyotrophic lateral sclerosis ... ALS is almost always fatal within two to three years.

  6. Alzheimer's Disease and Related Dementias - Department of Neurology - Mayo Clinic Research

    Multiple Sclerosis and Autoimmune Neurology · Neuromuscular Diseases · Neuro-Oncology · Pain and Headache · Sleep Neurology · Spinal Cord Disorders · Clinical ...

  7. A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    SGN-CD352A will be given every 4 weeks to a small group of patients with multiple myeloma. Participation eligibility. Participant eligibility includes age ...

  8. Medical Research & Education - Mayo Clinic News Network

    Root Cause of Multiple Myeloma Relapse Revealed. Dana Sparks. September 18 ... August 20, 2013. First · Previous ... 340 · 341 · 342 · 343 · 344 · 345 · 346 ...

  9. Neurosciences Clinical Trials - Medical Professionals - Mayo Clinic

    FTLD is a neurodegenerative disorder of the nervous system which there are no approved treatments or cures. The study has two arms: a “longitudinal arm” ...

  10. Medical Research & Education - Mayo Clinic News Network

    May 20, 2014. Cancer. Mayo Clinic First to Show Virotherapy is Promising Against Multiple Myeloma (pkg). Robert Nellis. May 16, 2014. Minnesota. Mayo Study ...